A family of sugar-based molecules for therapeutic use, includes compounds with a structure having at least one sugar molecule with carrier function, bound to arsenic having active principle function, allowing the selective therapeutic treatment of tumoral pathologies and not, distinguished by a high cellular metabolism and, consequently, by a high glucose consumption. Based on the preferential glucose absorption according to the Warburg effect, the compounds are adapted to penetrate inside tumoral cells and not, distinguished by a high cellular metabolism, via the glucose molecule integrated in their structure, so as to determine the selective therapeutic treatment of the cells and, consequently, of the pathologies deriving therefrom, by the arsenic molecule chemically bound to above mentioned glucose molecule. Processes for the production of synthetic sugar-based compounds and extracted sugar-based compounds, produced from natural sources are also described.
一种用于治疗的基于糖分子家族,包括具有至少一个带有载体功能的糖分子结构,与具有活性原理功能的
砷相结合的化合物,允许选择性治疗肿瘤病理和不具有高细胞代谢率和因此高
葡萄糖消耗率的病理的区别。基于Warburg效应的优先
葡萄糖吸收,这些化合物适应于通过其结构中集成的
葡萄糖分子穿透肿瘤细胞,而不是区别于高细胞代谢率的细胞,从而通过
化学上结合在上述
葡萄糖分子上的
砷分子确定对细胞和因此导致的病理的选择性治疗。还描述了生产合成糖基化合物和从
天然来源提取的糖基化合物的过程。